Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
24,490
+1,985
+9% +$160K 0.08% 193
2026
Q1
$1.59M Buy
22,505
+754
+3% +$56.5K 0.09% 192
2025
Q4
$1.72M Buy
21,751
+1,472
+7% +$117K 0.07% 215
2025
Q3
$1.67M Buy
+20,279
New +$1.6M 0.07% 227
2025
Q2
Sell
-3,732
Closed -$300K 965
2025
Q1
$300K Buy
+3,732
New +$310K 0.02% 638
2024
Q4
Sell
-3,150
Closed -$260K 908
2024
Q3
$260K Sell
3,150
-708
-18% -$52.9K 0.02% 512
2024
Q2
$271K Buy
+3,858
New +$275K 0.02% 491
2023
Q4
Sell
-4,411
Closed -$278K 674
2023
Q3
$278K Buy
+4,411
New +$275K 0.03% 425
2022
Q2
Sell
-27,994
Closed -$1.97M 780
2022
Q1
$1.97M Buy
+27,994
New +$1.89M 0.16% 131
2017
Q3
Sell
-7,819
Closed -$383K 282
2017
Q2
$383K Buy
+7,819
New +$363K 0.12% 235

Other funds holding MET

StoneX Group's MET Position: Q2 2026 in Review

StoneX Group increased its MetLife (MET) stake by 8.8% in Q2 2026, buying an estimated $160K and bringing the position to 24,490 shares worth $2.07M. The position accounts for 0.08% of the portfolio, ranked #193.

StoneX Group first reported a position in MET in Q2 2017 and has held it in 10 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • StoneX Group held 24,490 shares of MetLife worth $2.07M as of Q2 2026.
  • StoneX Group bought 1,985 MetLife shares in Q2 2026, an estimated $160K.
  • MetLife made up 0.08% of StoneX Group's portfolio in Q2 2026, its #193 holding.
  • StoneX Group first reported a position in MetLife in Q2 2017 and has held it in 10 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.